Felbatol Side Effects
Generic name: felbamate
Note: This document contains side effect information about felbamate. Some of the dosage forms listed on this page may not apply to the brand name Felbatol.
Some side effects of Felbatol may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to felbamate: oral suspension, oral tablet
Along with its needed effects, felbamate (the active ingredient contained in Felbatol) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking felbamate:More common
- Black, tarry stools
- chest pain
- loss of bladder control
- painful or difficult urination
- purple or red spots on the skin
- shakiness in the legs, arms, hands, or feet
- shortness of breath
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- swollen glands
- trembling or shaking of the hands or feet
- unusual bleeding or bruising
- unusual tiredness or weakness
- Agitation, aggression, or other mood or mental changes
- bladder pain
- bloody or cloudy urine
- bone pain
- burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
- clumsiness or unsteadiness
- frequent urge to urinate
- loss of appetite
- lower back or side pain
- skin rash
- swelling or puffiness of the face
- trouble with breathing
- unsteadiness, trembling, or other problems with muscle control or coordination
- Continuing headache
- continuing stomach pain
- continuing vomiting
- dark-colored urine
- general feeling of tiredness or weakness
- hives or itching
- light-colored stools
- muscle cramps
- nasal congestion
- nosebleeds or other unusual bruising or bleeding
- sensitivity of the skin to sunlight
- swollen or painful glands
- tightness in the chest
- yellow eyes or skin
Some side effects of felbamate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Acid or sour stomach
- bad, unusual, or unpleasant (after) taste
- body aches or pain
- change in taste
- change in walking and balance
- constricted, pinpoint, or small pupils (black part of the eye)
- difficulty having a bowel movement (stool)
- difficulty with sleeping
- double vision
- ear congestion
- loss of appetite
- loss of voice
- quick to react or overreact emotionally
- rapidly changing moods
- runny nose
- seeing double
- sleepiness or unusual drowsiness
- stomach discomfort, upset, or pain
- trouble sleeping
- unable to sleep
- weight loss
- Blemishes on the skin
- blurred vision
- decreased awareness or responsiveness
- decreased weight
- difficulty with moving
- joint pain
- muscle aching or cramping
- muscle pains or stiffness
- pain or tenderness around the eyes and cheekbones
- redness or swelling in the ear
- severe sleepiness
- swollen joints
- tender, swollen glands in the neck
- trouble with swallowing
- voice changes
For Healthcare Professionals
Applies to felbamate: oral suspension, oral tablet
In controlled trials with felbamate (the active ingredient contained in Felbatol) as monotherapy, no nervous system effect occurred with a frequency greater than 7%. However, the frequency of nervous system effects (particularly sedative effects) was much greater in controlled studies of felbamate as adjuvant therapy with other antiepileptic agents. Ataxia, tremor, involuntary movements, psychosis, and blurred vision have also been reported rarely.
One prospective investigation found 20 of 60 (33%) epileptic patients to have reported a headache. The headache was pounding in 11 patients, steady in 9 patients, and moderate or severe in 19 patients. Patients who had the headaches reported that they occurred at least once a week.
Nervous system side effects are common and include insomnia, headache, anxiety, dizziness, somnolence, fatigue, and lethargy.
Gastrointestinal side effects are common and include nausea, vomiting, dyspepsia, constipation, diarrhea, and bad taste in mouth. Some clinicians have reported that anorexia and weight loss occur commonly.
Dyspepsia and vomiting occur in as many as 9% of treated patients.
Hepatic side effects include mild elevations of liver function tests which occur in as many as 5% of treated patients. The manufacturer reports that several cases of acute liver failure have also occurred in patients taking felbamate (the active ingredient contained in Felbatol) A case of massive acute hepatic necrosis and death within 40 days of initiation of felbamate therapy has also been reported.
Dermatologic side effects including rashes and acne occur in approximately 3% of treated patients. The Stevens-Johnson syndrome has been reported rarely. A case of toxic epidermal necrolysis has also been reported.
Metabolic side effects including hypophosphatemia have been reported in approximately 3% of treated patients.
Hematologic side effects include leukopenia, thrombocytopenia, and agranulocytosis rarely. Nine cases of aplastic anemia have been reported in the United States from the time of commercial release of felbamate (the active ingredient contained in Felbatol) to August 1, 1994.
Genitourinary side effects including a case of urolithiasis have been reported.
Hypersensitivity side effects including a case of felbamate (the active ingredient contained in Felbatol) induced delayed anaphylaxis have been reported.
More Felbatol resources
- Felbatol Prescribing Information (FDA)
- Felbatol MedFacts Consumer Leaflet (Wolters Kluwer)
- Felbatol Concise Consumer Information (Cerner Multum)
- Felbatol Monograph (AHFS DI)
- Felbatol Advanced Consumer (Micromedex) - Includes Dosage Information
- Felbamate Professional Patient Advice (Wolters Kluwer)
- Felbamate Prescribing Information (FDA)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.